Germany is a sought-after location for conducting medical device clinical studies and in vitro diagnostic (IVD) performance evaluation studies. This article discusses certain aspects of conducting such studies in Germany, which if not clearly understood, can lead to unnecessary and costly delays.
Click here for full article by Maria E. Donawa, M.D and Silvia Pesci, Ph.D.
For more publications authored by Donawa Lifescience Consulting staff click here